Evidence map›Paper›PMID 30269865›Full record

ArticleBiological psychiatry2019

Noradrenergic Transmission at Alpha1-Adrenergic Receptors in the Ventral Periaqueductal Gray Modulates Arousal.

Kirsten A Porter-Stransky, Samuel W Centanni, Saumya L Karne, Lindsay M Odil, Sinda Fekir, Jennifer C Wong, Canaan Jerome, Heather A Mitchell, Andrew Escayg, Nigel P Pedersen and 3 more

Open access · greenAbstract read
In one paragraph

Article in Biological psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Article
  3. Impact of early locus coeruleus lesions in the TgF344 Alzheimer's disease rat model.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  4. Locus coeruleus-amygdala circuit disrupts prefrontal control to impair fear extinction.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Adenosine ABiological psychiatry · 2025
    Article
  9. Article
  10. Modulatory Neurotransmitter Genotypes Shape Dynamic Functional Connectome Reconfigurations.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Kirsten A Porter-StranskyDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia.
Samuel W CentanniDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee; Vanderbilt Center for Addiction Research, Vanderbilt University School of Medicine, Nashville, Tennessee.
Saumya L KarneDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia.
Lindsay M OdilProgram in Neuroscience, Christopher Newport University, Newport News, Virginia.
Sinda FekirProgram in Neuroscience, Christopher Newport University, Newport News, Virginia.
Jennifer C WongDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia.
Canaan JeromeDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia.
Heather A MitchellDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia.
Andrew EscaygDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia.
Nigel P PedersenDepartment of Neurology, Emory University School of Medicine, Atlanta, Georgia.
Danny G WinderDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee; Vanderbilt Center for Addiction Research, Vanderbilt University School of Medicine, Nashville, Tennessee.
Darlene A MitranoProgram in Neuroscience, Christopher Newport University, Newport News, Virginia; Department of Molecular Biology and Chemistry, Christopher Newport University, Newport News, Virginia.
David WeinshenkerDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia. Electronic address: dweinsh@emory.edu.
Emory University · USChristopher Newport University · USVanderbilt University · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
Virus Vector Shared ResourceP30CA016059 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Keri R Maher · 1985 to 2026
$51.0M
Research Project: Sensory and Multisensory Contributions to AutismU54HD083211 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DYKENS, ELISABETH MAY · 2015 to 2019
$7.1M
Udall Parkinson's Disease Center at Emory University: Circuitry to TherapyP50NS071669 · NINDS · EMORY UNIVERSITY · PI WICHMANN, THOMAS · 2010 to 2015
$6.8M
VCU Neuroscience Center Core GrantP30NS047463 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI POVLISHOCK, JOHN T · 2003 to 2013
$5.0M
Norepinephrine-dopamine interactions underlying arousalR01NS102306 · NINDS · EMORY UNIVERSITY · PI MITRANO, DARLENE A, WEINSHENKER, DAVID · 2017 to 2021
$1.8M
Control of the Hippocampal Formation by the Supramammillary Hypothalamus - Anatomy, Physiology and in a Model of Medial Temporal Lobe EpilepsyK08NS105929 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI PEDERSEN, NIGEL PAUL · 2018 to 2023
$963k
Functional Neuroanatomy Underlying Excessive SleepinessF32NS098615 · NINDS · EMORY UNIVERSITY · PI PORTER-STRANSKY, KIRSTEN A · 2016 to 2018
$178k
NCI NIH HHS P30 CA016059NICHD NIH HHS U54 HD083211NIH HHS P51 OD011132NINDS NIH HHS F32 NS098615NINDS NIH HHS K08 NS105929NINDS NIH HHS P30 NS047463NINDS NIH HHS P50 NS071669NINDS NIH HHS R01 NS102306
6 · The paper itself

Abstract

backgroundDysregulation of arousal is symptomatic of numerous psychiatric disorders. Previous research has shown that the activity of dopamine (DA) neurons in the ventral periaqueductal gray (vPAG) tracks with arousal state, and lesions of vPAG

methodsThis study combined designer receptors exclusively activated by designer drugs (DREADDs), behavioral pharmacology, electrophysiology, and immunoelectron microscopy in male and female mice to elucidate mechanisms in the vPAG that promote arousal.

resultsActivation of locus coeruleus projections to the vPAG or vPAG

conclusionsThese experiments revealed that vPAG α1ARs increase arousal, promote glutamatergic input onto vPAG

Indexed as

Action PotentialsAdrenergic alpha-1 Receptor AgonistsAdrenergic alpha-1 Receptor AntagonistsAnimalsArousalAstrocytesFemaleLocus CoeruleusMaleMicePeriaqueductal GrayReceptors, Adrenergic, alpha-1SleepAdrenergic alpha-1 Receptor AgonistsAdrenergic alpha-1 Receptor AntagonistsReceptors, Adrenergic, alpha-1ArousalAstrocytesDopamineDREADDsNorepinephrineSleepWakefulness

Identifiers

PMID30269865
PMCPMC6326840
OpenAlexW2887439750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.